预测非酒精性脂肪性肝病肝脏相关事件:一种预测模型
研究基于澳大利亚和西班牙的NAFLD患者随访长达28年,建立并验证了预测肝脏相关事件(LRE)的模型(NOS)。模型包含年龄、2型糖尿病、白蛋白、胆红素、血小板计数和国际标准化比值,在推导和验证队列中预测5年和10年LRE的准确性均优于纤维化-4指数或NAFLD纤维化评分。
要点
- NOS模型由年龄、2型糖尿病、白蛋白、胆红素、血小板计数和国际标准化比值构成。
- NOS评分≥1.3者5年累积LRE发生率为38%,低于此值者为1.0%。
- NOS模型在5年和10年预测LRE的准确性优于纤维化-4指数和NAFLD纤维化评分。
核心结论
- NOS模型由常规可获取的指标构成,预测NAFLD患者结局的准确性高于现有纤维化模型。
研究设计与样本
- 研究纳入来自澳大利亚和西班牙的NAFLD患者,随访长达28年,形成推导队列(n=584)和验证队列(n=477)。
- 采用竞争风险回归和信息准则进行模型开发,并用时间依赖AUC分析比较准确性。
主要发现
- 随访期间,推导队列52例(9%)和验证队列11例(2.3%)患者发生LRE。
- 年龄、2型糖尿病、白蛋白、胆红素、血小板计数和国际标准化比值是LRE的独立预测因素,合并为NAFLD结局评分(NOS)。
- NOS模型校准良好,校准斜率推导队列为0.99、验证队列为0.98;整体性能优异,集成Brier评分推导队列为0.07、验证队列为0.01。
- NOS评分≥1.3识别LRE高风险者,亚分布风险比(sub-HR)为24.6,p<0.001,5年累积发生率分别为38%和1.0%。
- 推导队列5年和10年时间依赖AUC分别为0.92和0.90,验证队列分别为0.80和0.82。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Management of NAFLD involves noninvasive prediction of fibrosis, which is a surrogate for patient outcomes. We aimed to develop and validate a model predictive of liver-related events (LREs) of decompensation and/or HCC and compare its accuracy with fibrosis models. APPROACH AND RESULTS: Patients with NAFLD from Australia and Spain who were followed for up to 28 years formed derivation (n = 584) and validation (n = 477) cohorts. Competing risk regression and information criteria were used for model development. Accuracy was compared with fibrosis models using time-dependent AUC analysis. During follow-up, LREs occurred in 52 (9%) and 11 (2.3%) patients in derivation and validation cohorts, respectively. Age, type 2 diabetes, albumin, bilirubin, platelet count, and international normalized ratio were independent predictors of LRE and were combined into a model [NAFLD outcomes score (NOS)]. The NOS model calibrated well [calibration slope, 0.99 (derivation), 0.98 (validation)] with excellent overall performance [integrated Brier score, 0.07 (derivation) and 0.01 (validation)]. A cutoff ≥1.3 identified subjects at a higher risk of LRE, (sub-HR 24.6, p < 0.001, 5-year cumulative incidence 38% vs 1.0%, respectively). The predictive accuracy at 5 and 10 years was excellent in both derivation (time-dependent AUC,0.92 and 0.90, respectively) and validation cohorts (time-dependent AUC,0.80 and 0.82, respectively). The NOS was more accurate than the fibrosis-4 or NAFLD fibrosis score for predicting LREs at 5 and 10 years ( p < 0.001). CONCLUSIONS: The NOS model consists of readily available measures and has greater accuracy in predicting outcomes in patients with NAFLD than existing fibrosis models.
引用
- Calzadilla-Bertot L, Jeffrey GP, Wang Z, et al. Predicting liver-related events in NAFLD: A predictive model. Hepatology. 2023. PMID: 36994693. doi:10.1097/HEP.0000000000000356
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。